The use of a patient-centric neuronal cell model of Beta-Propeller Protein-Associated Neurodegeneration (BPAN) as a platform to develop novel therapies

Awardee: Robin Ketteler

Institution: UCL MRC Laboratory for Molecular Cell Biology

Award Amount: $51,020

Funding Period: February 1, 2019 - January 31, 2020

Previous
Previous

Small molecule modulators of telomerase as novel treatments for dyskeratosis congenita

Next
Next

Mechanistic study of WDR45/45B and their binding partner ATG2 in the autophagy pathway of neural cells